Global Markets
Home›Global Markets›Trade & Tariffs›Trump to start generic drug tariffs in 2028, with a de…
Trump to start generic drug tariffs in 2028, with a delay for testing
The plan would introduce tariffs starting in 2028, while allowing time to test U.S. onshoring as the policy aims to reshuffle lower-cost generic drug production.
CNBC reports that President Donald Trump plans to impose tariffs on generic drugs starting in 2028, with an additional two-year delay tied to testing whether U.S. onshoring can be scaled.
The tariff plan is positioned as part of a broader effort to bring low-cost generic drug production back to the United States, targeting supply chains that currently rely on overseas manufacturing.
CNBC also notes that shifting away from established suppliers, including India, is not expected to be straightforward even with the timeline laid out in the proposal.